Mainolfi Nello's Form 4 filing
Kymera Therapeutics, Inc. (KYMR) · filed Oct 12, 2021
- Accession no.
- 0000899243-21-039857
- Filed
- Oct 12, 2021
- Trade date
- Oct 8-11, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.70M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mainolfi NelloCIK 0001821189 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2021 | Common Stock | MOption exerciseAcquired | +41,544 | $2.08 | +$86,411.52 | 505,743 | Direct | |
| Oct 8, 2021 | Common Stock | SSaleDisposed | −21,236 | $55.56F2 | −$1,179,872.16 | 484,507 | Direct | |
| Oct 8, 2021 | Common Stock | SSaleDisposed | −9,369 | $56.82F3 | −$532,346.58 | 475,138 | Direct | |
| Oct 8, 2021 | Common Stock | SSaleDisposed | −2,078 | $57.29F4 | −$119,048.62 | 473,060 | Direct | |
| Oct 8, 2021 | Common Stock | SSaleDisposed | −7,920 | $59.28F5 | −$469,497.6 | 465,140 | Direct | |
| Oct 8, 2021 | Common Stock | SSaleDisposed | −670 | $60.32F6 | −$40,414.4 | 464,470 | Direct | |
| Oct 8, 2021 | Common Stock | SSaleDisposed | −271 | $61.87 | −$16,766.77 | 464,199 | Direct | |
| Oct 11, 2021 | Common Stock | MOption exerciseAcquired | +6,456 | $2.08 | +$13,428.48 | 470,655 | Direct | |
| Oct 11, 2021 | Common Stock | SSaleDisposed | −5,712 | $53.58F7 | −$306,048.96 | 464,943 | Direct | |
| Oct 11, 2021 | Common Stock | SSaleDisposed | −744 | $54.50F8 | −$40,548 | 464,199 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2021 | Common Stock | MOption exerciseDisposed | −41,544 | $0.00 | $0 | 35,181 | Direct | |
| Oct 11, 2021 | Common Stock | MOption exerciseDisposed | −6,456 | $0.00 | $0 | 28,725 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.10 to $56.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.19 to $57.185. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.20 to $58.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.90 to $59.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.91 to $60.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.19 to $54.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.28 to $54.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.